New Key Statistics Module, Z-Score and F-Score
NAS:KNSA Key Ratios
| Market Cap $ M | 1,376.15 |
| Enterprise Value $ M | 1,174.74 |
| P/E(ttm) | 176.00 |
| PE Ratio without NRI | 176.00 |
| Forward PE Ratio | -- |
| Price/Book | 3.17 |
| Price/Sales | 4.66 |
| Price/Free Cash Flow | 64.75 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 301.00 |
| EPS (TTM) $ | 0.11 |
| Beneish M-Score | -1.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -219.60 |
| EV-to-EBIT | -38.46 |
| EV-to-EBITDA | -41.46 |
| PEG | -- |
| Shares Outstanding M | 71.08 |
| Net Margin (%) | 2.87 |
| Operating Margin % | -10.12 |
| Pre-tax Margin (%) | -7.15 |
| Quick Ratio | 3.79 |
| Current Ratio | 4.21 |
| ROA % (ttm) | 1.76 |
| ROE % (ttm) | 2.08 |
| ROIC % (ttm) | 4.65 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.99 |
KNSA Number of Guru Trades
KNSA Volume of Guru Trades
Gurus Latest Trades with NAS:KNSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KNSA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kiniksa Pharmaceuticals International PLC Insider Transactions
No Available Data
News about NAS:KNSA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers